Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT04052191
PHASE1
MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease
Sponsor: Honya Medical Inc
View on ClinicalTrials.gov
Summary
Safety evaluation of Intra-Coronary Administration of MCRcI® stem cells in Patients with Diffuse Coronary Artery Disease.
Official title: Intra-Coronary Administration of MCRcI® (Myo-Cardial Regenerative Cellular Injection) Improves Left Ventricular Function in Patients With Diffuse Coronary Artery Disease
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-12-01
Completion Date
2026-12-01
Last Updated
2024-10-03
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
MCRcI® stem cells
Intra-Coronary Administration of MCRcI® stem cells
Locations (1)
HONYA Medical Inc
Tainan, Taiwan